Skip to main content

Waters Corporation (WAT)

New York Stock Exchange Healthcare Medical - Diagnostics & ResearchView data quality →
49.9Fair

ValueMarkers Composite Index

Top 32%#30,492 of 44,707
Overvalued

26% above intrinsic value ($254)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-1.63
High Risk
Altman
6.20
Safe
DCF Value
$254
Overvalued
ROIC
14.1%
Adequate
P/E
30.1
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Waters Corporation (WAT) — VMCI valuation read

WAT prints VMCI 50/100 inside the Healthcare sector, where the median sits at 50. The 0-point below-median delta is the cleanest single-number summary of Waters Corporation's composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On WAT, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** WAT trades at 18.0x earnings, 0% above the Healthcare median of 18.0x; that is the value line. ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 1.9x is the rate-sensitivity line to watch; that is the risk line for Waters Corporation on the trailing financials.

WAT rose 2.1% over the trailing 7 days, with a -20.0% read on a 30-day basis.

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

CEO: Udit Batra7,600 employeesUSwww.waters.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in WAT’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.